Stewart M J, Pretlow T G, Hiramoto R
Am J Pathol. 1972 Jul;68(1):163-82.
In attempting to quantitate immunoglobulin synthesis by ascites myeloma cells, we were surprised to note that malignant appearing cells never exceeded 35.9 = 28.0% of ascitic cells and exceeded 22.4 +/- 23.8% of ascitic cells on only one day between the transplantation of the tumor and the death of the host. The ascites tumor suspensions were separated primarily according to diameter, using a previously described isokinetic density gradient of Ficoll in tissue culture medium. This separation resulted in four modal populations of cells: red blood cells, lymphoid cells, macrophages and myeloma cells. The modal populations of macrophages and lymphoid cells always contained less than 0.2% myeloma cells. The purified cells were tested for tumorigenicity. The animal which received the largest number of cells from the macrophage zone received 296 times the number of cells which had been determined to be tumorigenic for myeloma cells. The animal which received the largest number of cells from the lymphoid zone received 1600 times the tumorigenic dose for myeloma cells. Neither of these animals has become ill 4 months after receiving the purified cells. We conclude that: a) Experimentalists who use ascites tumors are not justified in assuming that even easily detected quantitative differences between benign and malignant tissues would be reflected in analyses performed using unstandardized unexamined ascites tumor suspensions. b) In the case of the MOPC 104 mouse myeloma, cytologic criteria are adequate for distinguishing malignant cells from the inflammatory cells in the ascites suspension with a high degree of correspondence between cytologic appearance and biologic activity. c) Programmed gradient sedimentation in an isokinetic gradient of Ficoll in tissue culture medium is an effective means of separating malignant cells from benign cells in this particular ascites tumor.
在试图对腹水骨髓瘤细胞的免疫球蛋白合成进行定量时,我们惊讶地发现,外观呈恶性的细胞从未超过腹水细胞的35.9±28.0%,且在肿瘤移植至宿主死亡之间仅一天超过腹水细胞的22.4±23.8%。腹水肿瘤悬液主要根据直径进行分离,采用先前描述的组织培养基中Ficoll等速密度梯度。这种分离产生了四个细胞模态群体:红细胞、淋巴细胞、巨噬细胞和骨髓瘤细胞。巨噬细胞和淋巴细胞的模态群体中骨髓瘤细胞含量始终低于0.2%。对纯化后的细胞进行致瘤性检测。从巨噬细胞区获得细胞数量最多的动物,其获得的细胞数量是已确定对骨髓瘤细胞具有致瘤性的细胞数量的296倍。从淋巴细胞区获得细胞数量最多的动物,其获得的细胞数量是骨髓瘤细胞致瘤剂量的1600倍。在接受纯化细胞4个月后,这两只动物均未发病。我们得出以下结论:a)使用腹水肿瘤的实验人员没有理由假定,即使良性和恶性组织之间易于检测到的定量差异,也会在使用未经标准化和检查的腹水肿瘤悬液进行的分析中得到体现。b)就MOPC 104小鼠骨髓瘤而言,细胞学标准足以将恶性细胞与腹水悬液中的炎性细胞区分开来,细胞学外观与生物学活性之间具有高度一致性。c)在组织培养基中Ficoll等速梯度中进行程序梯度沉降,是在这种特定腹水肿瘤中将恶性细胞与良性细胞分离的有效方法。